Assessment of long-term safety and efficacy of intranasal Mesenchymal Stem … – Nature.com
|
Assessment of long-term safety and efficacy of intranasal Mesenchymal Stem …
Nature.com For clinical translation, we assessed whether intranasal mesenchymal stem cell (MSC) treatment after hypoxia-ischemia (HI) induces neoplasia in the brain or periphery at 14 months. Furthermore, the long-term effects of MSCs on behavior and lesion size … |
